Stock Details
ABBV is AbbVie Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 142.12$. Average daily volumn in 3 months 5.38M. Market cap 252.94B

Stock symbol : ABBV. Exchange : NYSE. Currency : USD
Lastest price : 143.06$. Total volume : 5.75M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

AbbVie Inc. (ABBV)
Last Price

Previous Close143.01
Day Range140.95-143.38
Bid142.64 x 900
Ask142.78 x 800
Average Volume5.38M
Market Cap252.94B
52 Week Range106.86-175.91
Trailing P/E20.23
Foward P/E12.02
Dividend (Yield %)3.94%
Ex-Dividend Date2022-10-13

Financial Details

According to AbbVie Inc.'s financial reports the company's revenue in 2021 were 56.2B an increase( +24.44%) over the years 2020 revenue that were of 45.8B. In 2021 the company's total earnings were 11.54B while total earnings in 2020 were 4.62B( +175%).

Loading ...


AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behรงet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCL... EXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Market Cap:
Total Assets:
Total Cash:

News about "AbbVie Inc."


AbbVie Inc.'s (NYSE:ABBV) Business Is Trailing The Market But Its Shares Aren't

Source from : YAHOO!Finance - 11 hours ago

With a price-to-earnings (or "P/E") ratio of 20.1x AbbVie Inc. ( NYSE:ABBV ) may be sending bearish signals at ...See details»


AbbVie Inc. (NYSE:ABBV) Shares Sold by Carnegie Capital Asset Management LLC

Source from : Defense World - 1 days ago

Carnegie Capital Asset Management LLC cut its holdings in shares of AbbVie Inc. (NYSE:ABBV โ€“ Get Rating) by 42.1% in the 2nd quarter, according to the company in its most recent disclosure with the ...See details»


AbbVie Inc. (NYSE:ABBV) Shares Sold by Inlet Private Wealth LLC

Source from : Defense World - 2 days ago

Inlet Private Wealth LLC decreased its stake in shares of AbbVie Inc. (NYSE:ABBV โ€“ Get Rating) by 0.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned ...See details»

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?

Source from : YAHOO!Finance - 3 days ago

AbbVie (ABBV) has received quite a bit of attention from users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.See details»

AbbVie Receives CHMP Positive Opinion For Skyrizi For Moderate To Severe Crohn's Disease

Source from : Nasdaq - 5 days ago

(RTTNews) - AbbVie Inc. (ABBV) said on Monday that the Committee for Medicinal Products for Human Use has adopted positive opinion to extend the indication of Skyrizi for the treatment of adults ...See details»

Analysts Mean recommendation for AbbVie Inc. (ABBV) was 2.20: Is this the key time?

Source from : investchronicle - 11 days ago

AbbVie Inc. (ABBV) is priced at $142.24 after the most recent trading session. At the very opening of the session, the stock price was $141.01 and reached a high price of $142.87, prior to closing the ...See details»

Bristol Myers, AbbVie plan to cut up to 360 California jobs

Source from : Reuters - 8 days ago

Sept 16 (Reuters) - Drugmakers Bristol Myers Squibb Co (BMY.N) and AbbVie Inc told California officials that they plan to cut up to 360 jobs there in unrelated moves, according to notices filed ...See details»

Abbvie Inc

Source from : U.S. News & World Report - 5 days ago

Here are the highest-rated stocks from Warren Buffett's portfolio, according to analysts.See details»


The Zacks Analyst Blog Highlights Apple, Amazon, AbbVie, Philip Morris International and BlackRock

Source from : YAHOO!News - 4 days ago

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc.,, Inc. and ...See details»

AbbVie Inc.'s (ABBV) Management Presents at Morgan Stanley 20th Annual Global Healthcare Conference (Transcript)

Source from : Seeking Alpha - 11 days ago

I am Terence Flynn the U.S. pharma analyst here at Morgan Stanley. We are very pleased to be hosting AbbVie today. First, before we get started, for important disclosures, please see the Morgan ...See details»

Top Analyst Reports for Apple, & AbbVie

Source from : Nasdaq - 5 days ago

Inc. (AMZN) and AbbVie Inc. (ABBV). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of todayโ€™s research reports here ...See details»

New Suit - Product Liability

Source from : Law - 5 days ago

Counsel have not yet appeared for the defendants. The case is 1:22-cv-00787, Stanley et al v. Abbvie Inc. et al.See details»

Male Hypogonadism Market Size to Grow by USD 684.95 Mn, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio

Source from : The Victoria Advocate - 5 days ago

NEW YORK, Sept. 19, 2022 /PRNewswire/ -- The male hypogonadism market has been segmented by type (Klinefelter syndrome, Kallmann syndrome, and pituitary disorders) and geography (North America ...See details»

Enzyme Replacement Therapy Market See Huge Growth for New Normal | Takeda Pharmaceutical Company Limited, Sanofi S.A., AbbVie Inc.

Source from : Digital Journal - 8 days ago

New Jersey (United States) The Enzyme Replacement Therapy Market research report provides all the information related to the industry. It gives the markets outlook by giving authentic data to its ...See details»